Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Alcoholic β-glucoside found in willow bark, sa...
Mixture of terpene lactones found in Ginkgo.
Nucleoside (thymidine) analog; RT inhibitor.
Efflux pump inhibitor
Dual mTORC1/mTORC2 inhibitor.
Atazanavir metabolite; HIV protease inhibitor.<...
Smoothened agonist.
DNA alkylator.
Type A trichothecene mycotoxin produced by Fusa...
ITC, erucin analog.
Endogenous peptide neurotransmitter, involved i...
Thiamine/vitamin B derivative, antioxidant.
PKMYT1 inhibitor
Peptide, substance P analog; NK agonist.
BCL-XL specific degrader
Piperazine; 5-HT1 agonist, 5-HT2/3 and α2-adre...
Macrolide; protein translation inhibitor, mamma...
Benzimidazole; microtubule polymerization inhib...
5-HT3 antagonist.
Retinoid; RARα/β/γ agonist.